Skip to Content
Merck
CN

61250

DL-Kynurenine

≥95.0% (NT), for peptide synthesis

Synonym(s):

2-Amino-3-(2-aminobenzoyl)propionic acid, 2-Amino-4-(2-aminophenyl)-4-oxobutyric acid

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C10H12N2O3
CAS Number:
Molecular Weight:
208.21
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352209
EC Number:
206-445-9
MDL number:
Beilstein/REAXYS Number:
2697333
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

DL-Kynurenine, ≥95.0% (NT)

Quality Level

assay

≥95.0% (NT)

form

powder

mp

~235 °C (dec.)

application(s)

peptide synthesis

SMILES string

NC(CC(=O)c1ccccc1N)C(O)=O

InChI

1S/C10H12N2O3/c11-7-4-2-1-3-6(7)9(13)5-8(12)10(14)15/h1-4,8H,5,11-12H2,(H,14,15)

InChI key

YGPSJZOEDVAXAB-UHFFFAOYSA-N



Still not finding the right product?

Explore all of our products under DL-Kynurenine


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Ye Lu et al.
Journal of clinical biochemistry and nutrition, 58(3), 210-215 (2016-06-04)
Postoperative fatigue syndrome is a general complication after surgery. However, there is no ''gold standard'' for fatigue assessment due to the lack of objective biomarkers. In this study, a rodent model of postoperative fatigue syndrome based on partial hepatectomy was
Adam K Walker et al.
Molecular psychiatry, 24(10), 1523-1532 (2018-07-11)
Inflammation activates indoleamine 2,3-dioxygenase (IDO) which metabolizes tryptophan into kynurenine. Circulating kynurenine is transported into the brain by the large amino transporter LAT1 at the level of the blood-brain barrier. We hypothesized that administration of leucine that has a high
László Vécsei et al.
Nature reviews. Drug discovery, 12(1), 64-82 (2012-12-15)
Various pathologies of the central nervous system (CNS) are accompanied by alterations in tryptophan metabolism. The main metabolic route of tryptophan degradation is the kynurenine pathway; its metabolites are responsible for a broad spectrum of effects, including the endogenous regulation



Global Trade Item Number

SKUGTIN
61250-1G04061826095416
61250-250MG04061832595276